How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic

Gilead gains accelerated FDA approval for rare liver disease treatment

FDA lifts hold on BioNTech and MediLink's ADC trial After safety revisions

Breakthrough delivery system could transform Alzheimer’s treatment

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Breaking News: Lecanemab approved in UK but unavailable on NHS

Highlights

array(40) {
  [0]=>
  string(4) "8213"
  ["article_id"]=>
  string(4) "8213"
  [1]=>
  string(84) "New genetic test could pick out ‘high risk’ bone marrow cancer patients"
  ["article_title"]=>
  string(84) "New genetic test could pick out ‘high risk’ bone marrow cancer patients"
  [2]=>
  string(150) "Picking out patients whose cancers have high-risk genetic features could help clinicians realise sooner if they’re unlikely to respond to treatm"
  ["short_description"]=>
  string(150) "Picking out patients whose cancers have high-risk genetic features could help clinicians realise sooner if they’re unlikely to respond to treatm"
  [3]=>
  string(218) "Picking out patients whose cancers have high-risk genetic features could help clinicians realise sooner if they’re unlikely to respond to treatment, enabling them to find alternative options as early as possible."
  ["description"]=>
  string(218) "Picking out patients whose cancers have high-risk genetic features could help clinicians realise sooner if they’re unlikely to respond to treatment, enabling them to find alternative options as early as possible."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(109) "http://www.pharmatimes.com/news/new_genetic_test_could_pick_out_high_risk_bone_marrow_cancer_patients_1328922"
  ["blog_url"]=>
  string(109) "http://www.pharmatimes.com/news/new_genetic_test_could_pick_out_high_risk_bone_marrow_cancer_patients_1328922"
  [15]=>
  string(19) "2020-03-11 19:31:59"
  ["add_date"]=>
  string(19) "2020-03-11 19:31:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:50:34"
  ["create_at"]=>
  string(19) "2020-03-12 15:50:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

New genetic test could pick out ‘high risk’ bone marrow cancer patients

Picking out patients whose cancers have high-risk genetic features could help clinicians realise sooner if they’re

array(40) {
  [0]=>
  string(4) "8238"
  ["article_id"]=>
  string(4) "8238"
  [1]=>
  string(84) "RadNet to Acquire DeepHealth, Inc., Expanding its Efforts in Artificial Intelligence"
  ["article_title"]=>
  string(84) "RadNet to Acquire DeepHealth, Inc., Expanding its Efforts in Artificial Intelligence"
  [2]=>
  string(150) "LOS ANGELES, March  11, 2020  (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site"
  ["short_description"]=>
  string(150) "LOS ANGELES, March  11, 2020  (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site"
  [3]=>
  string(523) "
LOS ANGELES, March  11, 2020  (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has executed a definitive agreement to acquire DeepHealth, Inc. (“DeepHealth”), a leading radiology artificial intelligence (“AI”) and machine learning company initially focused on solutions for the medical interpretation of mammography exams.
"
  ["description"]=>
  string(523) "
LOS ANGELES, March  11, 2020  (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has executed a definitive agreement to acquire DeepHealth, Inc. (“DeepHealth”), a leading radiology artificial intelligence (“AI”) and machine learning company initially focused on solutions for the medical interpretation of mammography exams.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(152) "http://www.globenewswire.com/news-release/2020/03/11/1998565/0/en/RadNet-to-Acquire-DeepHealth-Inc-Expanding-its-Efforts-in-Artificial-Intelligence.html"
  ["blog_url"]=>
  string(152) "http://www.globenewswire.com/news-release/2020/03/11/1998565/0/en/RadNet-to-Acquire-DeepHealth-Inc-Expanding-its-Efforts-in-Artificial-Intelligence.html"
  [15]=>
  string(19) "2020-03-11 18:00:00"
  ["add_date"]=>
  string(19) "2020-03-11 18:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:55:55"
  ["create_at"]=>
  string(19) "2020-03-12 15:55:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

RadNet to Acquire DeepHealth, Inc., Expanding its Efforts in Artificial Intelligence

LOS ANGELES, March 11, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), 

array(40) {
  [0]=>
  string(4) "8273"
  ["article_id"]=>
  string(4) "8273"
  [1]=>
  string(19) "Making privacy work"
  ["article_title"]=>
  string(19) "Making privacy work"
  [2]=>
  string(155) "Europe’s GDPR has been considered a trailblazer. But it turns out that interpreting it is difficult, and digital healthcare is where these difficult"
  ["short_description"]=>
  string(155) "Europe’s GDPR has been considered a trailblazer. But it turns out that interpreting it is difficult, and digital healthcare is where these difficult"
  [3]=>
  string(177) "Europe’s GDPR has been considered a trailblazer. But it turns out that interpreting it is difficult, and digital healthcare is where these difficulties manifest most.&#nl"
  ["description"]=>
  string(177) "Europe’s GDPR has been considered a trailblazer. But it turns out that interpreting it is difficult, and digital healthcare is where these difficulties manifest most.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(64) "https://www.healthcareitnews.com/news/europe/making-privacy-work"
  ["blog_url"]=>
  string(64) "https://www.healthcareitnews.com/news/europe/making-privacy-work"
  [15]=>
  string(19) "2020-03-11 17:15:45"
  ["add_date"]=>
  string(19) "2020-03-11 17:15:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:22"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Making privacy work

Europe’s GDPR has been considered a trailblazer. But it turns out that interpreting it is difficult, and digital 

array(40) {
  [0]=>
  string(4) "8214"
  ["article_id"]=>
  string(4) "8214"
  [1]=>
  string(36) "Final chance to enter into CROY 2020"
  ["article_title"]=>
  string(36) "Final chance to enter into CROY 2020"
  [2]=>
  string(139) "The 2020 Clinical Researcher of the Year – The Americas competition will be closing for entry at midnight this Friday the 13th March."
  ["short_description"]=>
  string(139) "The 2020 Clinical Researcher of the Year – The Americas competition will be closing for entry at midnight this Friday the 13th March."
  [3]=>
  string(139) "The 2020 Clinical Researcher of the Year – The Americas competition will be closing for entry at midnight this Friday the 13th March."
  ["description"]=>
  string(139) "The 2020 Clinical Researcher of the Year – The Americas competition will be closing for entry at midnight this Friday the 13th March."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(76) "http://www.pharmatimes.com/news/final_chance_to_enter_into_croy_2020_1328704"
  ["blog_url"]=>
  string(76) "http://www.pharmatimes.com/news/final_chance_to_enter_into_croy_2020_1328704"
  [15]=>
  string(19) "2020-03-11 17:04:54"
  ["add_date"]=>
  string(19) "2020-03-11 17:04:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:50:34"
  ["create_at"]=>
  string(19) "2020-03-12 15:50:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Final chance to enter into CROY 2020

The 2020 Clinical Researcher of the Year – The Americas competition will be closing for entry at midnight this Fri

array(40) {
  [0]=>
  string(4) "8219"
  ["article_id"]=>
  string(4) "8219"
  [1]=>
  string(52) "AA Still Best to Beat Problem Drinking, Review Finds"
  ["article_title"]=>
  string(52) "AA Still Best to Beat Problem Drinking, Review Finds"
  [2]=>
  string(154) "WEDNESDAY, March 11, 2020 -- For people who want to stop drinking, the world's oldest alcohol support group is still the best way, a new review conclu"
  ["short_description"]=>
  string(154) "WEDNESDAY, March 11, 2020 -- For people who want to stop drinking, the world's oldest alcohol support group is still the best way, a new review conclu"
  [3]=>
  string(257) "WEDNESDAY, March 11, 2020 -- For people who want to stop drinking, the world's oldest alcohol support group is still the best way, a new review concludes.&#nlIn an analysis of 27 studies, researchers found that Alcoholics Anonymous was typically more..."
  ["description"]=>
  string(257) "WEDNESDAY, March 11, 2020 -- For people who want to stop drinking, the world's oldest alcohol support group is still the best way, a new review concludes.&#nlIn an analysis of 27 studies, researchers found that Alcoholics Anonymous was typically more..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(184) "https://www.drugs.com/news/aa-still-best-beat-problem-drinking-review-finds-88862.html?utm_source=ddc&utm_medium=rss&utm_campaign=AA+Still+Best+to+Beat+Problem+Drinking%2C+Review+Finds"
  ["blog_url"]=>
  string(184) "https://www.drugs.com/news/aa-still-best-beat-problem-drinking-review-finds-88862.html?utm_source=ddc&utm_medium=rss&utm_campaign=AA+Still+Best+to+Beat+Problem+Drinking%2C+Review+Finds"
  [15]=>
  string(19) "2020-03-11 17:03:42"
  ["add_date"]=>
  string(19) "2020-03-11 17:03:42"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:50:34"
  ["create_at"]=>
  string(19) "2020-03-12 15:50:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

AA Still Best to Beat Problem Drinking, Review Finds

WEDNESDAY, March 11, 2020 -- For people who want to stop drinking, the world's oldest alcohol support group is still

array(40) {
  [0]=>
  string(4) "8220"
  ["article_id"]=>
  string(4) "8220"
  [1]=>
  string(33) "Health Highlights: March 11, 2020"
  ["article_title"]=>
  string(33) "Health Highlights: March 11, 2020"
  [2]=>
  string(153) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlFDA Halts Inspections of Foreign Plants Due to"
  ["short_description"]=>
  string(153) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlFDA Halts Inspections of Foreign Plants Due to"
  [3]=>
  string(252) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlFDA Halts Inspections of Foreign Plants Due to Coronavirus&#nlNearly all U.S. Food and Drug Administration inspections of overseas plants that..."
  ["description"]=>
  string(252) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlFDA Halts Inspections of Foreign Plants Due to Coronavirus&#nlNearly all U.S. Food and Drug Administration inspections of overseas plants that..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(150) "https://www.drugs.com/news/health-highlights-march-11-2020-88864.html?utm_source=ddc&utm_medium=rss&utm_campaign=Health+Highlights%3A+March+11%2C+2020"
  ["blog_url"]=>
  string(150) "https://www.drugs.com/news/health-highlights-march-11-2020-88864.html?utm_source=ddc&utm_medium=rss&utm_campaign=Health+Highlights%3A+March+11%2C+2020"
  [15]=>
  string(19) "2020-03-11 16:03:35"
  ["add_date"]=>
  string(19) "2020-03-11 16:03:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:50:34"
  ["create_at"]=>
  string(19) "2020-03-12 15:50:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Health Highlights: March 11, 2020

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlFDA Halts Ins

array(40) {
  [0]=>
  string(4) "8200"
  ["article_id"]=>
  string(4) "8200"
  [1]=>
  string(80) "Australia's PrimaryClinic and HealthEngine introduce measures to tackle COVID-19"
  ["article_title"]=>
  string(80) "Australia's PrimaryClinic and HealthEngine introduce measures to tackle COVID-19"
  [2]=>
  string(150) "A new update implemented by the Australian Federal Government will allow doctors, nurses and mental health practitioners to provide telehealth service"
  ["short_description"]=>
  string(150) "A new update implemented by the Australian Federal Government will allow doctors, nurses and mental health practitioners to provide telehealth service"
  [3]=>
  string(238) "A new update implemented by the Australian Federal Government will allow doctors, nurses and mental health practitioners to provide telehealth services, such as video conferencing to people isolated at home due to the coronavirus. &#nl"
  ["description"]=>
  string(238) "A new update implemented by the Australian Federal Government will allow doctors, nurses and mental health practitioners to provide telehealth services, such as video conferencing to people isolated at home due to the coronavirus. &#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(128) "https://www.healthcareitnews.com/news/asia-pacific/australia-s-primaryclinic-and-healthengine-introduce-measures-tackle-covid-19"
  ["blog_url"]=>
  string(128) "https://www.healthcareitnews.com/news/asia-pacific/australia-s-primaryclinic-and-healthengine-introduce-measures-tackle-covid-19"
  [15]=>
  string(19) "2020-03-11 15:37:33"
  ["add_date"]=>
  string(19) "2020-03-11 15:37:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:13"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:13"
  [19]=>
  string(80) "Australia_s_PrimaryClinic_and_HealthEngine_introduce_measures_to_tackle_COVID-19"
  ["slug"]=>
  string(80) "Australia_s_PrimaryClinic_and_HealthEngine_introduce_measures_to_tackle_COVID-19"
}

Australia's PrimaryClinic and HealthEngine introduce measures to tackle COVID-19

A new update implemented by the Australian Federal Government will allow doctors, nurses and mental health practitioners

array(40) {
  [0]=>
  string(4) "8274"
  ["article_id"]=>
  string(4) "8274"
  [1]=>
  string(87) "Australia’s PrimaryClinic and HealthEngine introduce measures to tackle COVID-19"
  ["article_title"]=>
  string(87) "Australia’s PrimaryClinic and HealthEngine introduce measures to tackle COVID-19"
  [2]=>
  string(150) "A new update implemented by the Australian federal government will allow doctors, nurses and mental health practitioners to provide telehealth service"
  ["short_description"]=>
  string(150) "A new update implemented by the Australian federal government will allow doctors, nurses and mental health practitioners to provide telehealth service"
  [3]=>
  string(239) "A new update implemented by the Australian federal government will allow doctors, nurses and mental health practitioners to provide telehealth services, such as video conferencing, to people isolated at home due to the coronavirus. &#nl"
  ["description"]=>
  string(239) "A new update implemented by the Australian federal government will allow doctors, nurses and mental health practitioners to provide telehealth services, such as video conferencing, to people isolated at home due to the coronavirus. &#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(128) "https://www.healthcareitnews.com/news/asia-pacific/australia-s-primaryclinic-and-healthengine-introduce-measures-tackle-covid-19"
  ["blog_url"]=>
  string(128) "https://www.healthcareitnews.com/news/asia-pacific/australia-s-primaryclinic-and-healthengine-introduce-measures-tackle-covid-19"
  [15]=>
  string(19) "2020-03-11 15:37:33"
  ["add_date"]=>
  string(19) "2020-03-11 15:37:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:22"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Australia’s PrimaryClinic and HealthEngine introduce measures to tackle COVID-19

A new update implemented by the Australian federal government will allow doctors, nurses and mental health practitioners

array(40) {
  [0]=>
  string(4) "8054"
  ["article_id"]=>
  string(4) "8054"
  [1]=>
  string(39) "Result of Extraordinary General Meeting"
  ["article_title"]=>
  string(39) "Result of Extraordinary General Meeting"
  [2]=>
  string(77) "IBA commits to a sustainable stakeholder approach and introduces loyalty vote"
  ["short_description"]=>
  string(77) "IBA commits to a sustainable stakeholder approach and introduces loyalty vote"
  [3]=>
  string(120) "
IBA commits to a sustainable stakeholder approach and introduces loyalty vote
"
  ["description"]=>
  string(120) "
IBA commits to a sustainable stakeholder approach and introduces loyalty vote
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "25"
  ["rss_id"]=>
  string(2) "25"
  [14]=>
  string(110) "http://www.globenewswire.com/news-release/2020/03/11/1998472/0/en/Result-of-Extraordinary-General-Meeting.html"
  ["blog_url"]=>
  string(110) "http://www.globenewswire.com/news-release/2020/03/11/1998472/0/en/Result-of-Extraordinary-General-Meeting.html"
  [15]=>
  string(19) "2020-03-11 14:00:00"
  ["add_date"]=>
  string(19) "2020-03-11 14:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:34"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Result of Extraordinary General Meeting

IBA commits to a sustainable stakeholder approach and introduces loyalty vote

array(40) {
  [0]=>
  string(4) "8055"
  ["article_id"]=>
  string(4) "8055"
  [1]=>
  string(115) "Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention"
  ["article_title"]=>
  string(115) "Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention"
  [2]=>
  string(157) "Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec® PLUS Cytology a"
  ["short_description"]=>
  string(157) "Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec® PLUS Cytology a"
  [3]=>
  string(2339) "
Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec® PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas® 4800 HPV Test. This biomarker technology simplifies clinical decision making by providing easy to understand results so that clinicians and women are clear on next steps.
 
 The CINtec PLUS Cytology test identifies those women whose HPV infections are most likely to be associated with cervical pre-cancers. It enables clinicians to more confidently determine which women should be referred to immediate further diagnostic procedures, helping to prevent women from developing more advanced cervical disease.
 
 About 13,800 new cases of invasive cervical cancer will be diagnosed in the US in 2020, according to the American Cancer Society, and about 4,290 women will die from the disease this year. Persistent infection with HPV is the principal cause of cervical cancer, with the virus implicated in more than 99 percent of cervical cancers worldwide.
 
 “Despite being nearly 100 percent preventable, cervical cancer is still one of the most common cancers in women worldwide. To address this, Roche is dedicated to investing in next-generation biomarkers that will significantly advance screening strategies and support global efforts to eradicate this disease,” said Thomas Schinecker, CEO, Roche Diagnostics. “We are committed to providing women with the protection and care they deserve.” While most HPV infections resolve on their own, some women who test positive for the virus or whose co-testing results are inconclusive – HPV-positive and Pap cytology-negative – may develop pre-cancerous cervical lesions that, if left untreated, may progress to cervical cancer. Early identification of women who are most at risk is vital.
 
 CINtec PLUS Cytology provides definitive information about which HPV-positive women may benefit most from immediate referral to colposcopy versus repeat testing. This is a major step forward to individualize a woman’s care and prevent both overtreatment and undertreatment.
"
  ["description"]=>
  string(2339) "
Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec® PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas® 4800 HPV Test. This biomarker technology simplifies clinical decision making by providing easy to understand results so that clinicians and women are clear on next steps.
 
 The CINtec PLUS Cytology test identifies those women whose HPV infections are most likely to be associated with cervical pre-cancers. It enables clinicians to more confidently determine which women should be referred to immediate further diagnostic procedures, helping to prevent women from developing more advanced cervical disease.
 
 About 13,800 new cases of invasive cervical cancer will be diagnosed in the US in 2020, according to the American Cancer Society, and about 4,290 women will die from the disease this year. Persistent infection with HPV is the principal cause of cervical cancer, with the virus implicated in more than 99 percent of cervical cancers worldwide.
 
 “Despite being nearly 100 percent preventable, cervical cancer is still one of the most common cancers in women worldwide. To address this, Roche is dedicated to investing in next-generation biomarkers that will significantly advance screening strategies and support global efforts to eradicate this disease,” said Thomas Schinecker, CEO, Roche Diagnostics. “We are committed to providing women with the protection and care they deserve.” While most HPV infections resolve on their own, some women who test positive for the virus or whose co-testing results are inconclusive – HPV-positive and Pap cytology-negative – may develop pre-cancerous cervical lesions that, if left untreated, may progress to cervical cancer. Early identification of women who are most at risk is vital.
 
 CINtec PLUS Cytology provides definitive information about which HPV-positive women may benefit most from immediate referral to colposcopy versus repeat testing. This is a major step forward to individualize a woman’s care and prevent both overtreatment and undertreatment.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "25"
  ["rss_id"]=>
  string(2) "25"
  [14]=>
  string(186) "http://www.globenewswire.com/news-release/2020/03/11/1998477/0/en/Roche-receives-FDA-approval-for-CINtec-PLUS-Cytology-test-to-aid-clinicians-in-improving-cervical-cancer-prevention.html"
  ["blog_url"]=>
  string(186) "http://www.globenewswire.com/news-release/2020/03/11/1998477/0/en/Roche-receives-FDA-approval-for-CINtec-PLUS-Cytology-test-to-aid-clinicians-in-improving-cervical-cancer-prevention.html"
  [15]=>
  string(19) "2020-03-11 14:00:00"
  ["add_date"]=>
  string(19) "2020-03-11 14:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:34"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving c

Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA

array(40) {
  [0]=>
  string(4) "8056"
  ["article_id"]=>
  string(4) "8056"
  [1]=>
  string(50) "Bone Therapeutics announces 2019 full year results"
  ["article_title"]=>
  string(50) "Bone Therapeutics announces 2019 full year results"
  [2]=>
  string(21) "Regulated information"
  ["short_description"]=>
  string(21) "Regulated information"
  [3]=>
  string(45) "
Regulated information
"
  ["description"]=>
  string(45) "
Regulated information
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "25"
  ["rss_id"]=>
  string(2) "25"
  [14]=>
  string(121) "http://www.globenewswire.com/news-release/2020/03/11/1998478/0/en/Bone-Therapeutics-announces-2019-full-year-results.html"
  ["blog_url"]=>
  string(121) "http://www.globenewswire.com/news-release/2020/03/11/1998478/0/en/Bone-Therapeutics-announces-2019-full-year-results.html"
  [15]=>
  string(19) "2020-03-11 14:00:00"
  ["add_date"]=>
  string(19) "2020-03-11 14:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:34"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Bone Therapeutics announces 2019 full year results

Regulated information

array(40) {
  [0]=>
  string(4) "8089"
  ["article_id"]=>
  string(4) "8089"
  [1]=>
  string(147) "GroupSystems Corp. offers complimentary access to its ThinkTank® digital engagement platform for businesses during COVID-19 Coronavirus outbreak"
  ["article_title"]=>
  string(147) "GroupSystems Corp. offers complimentary access to its ThinkTank® digital engagement platform for businesses during COVID-19 Coronavirus outbreak"
  [2]=>
  string(150) "DENVER, March 11, 2020 /PRNewswire/ -- GroupSystems, the leading provider of digital engagement and workshop facilitation, has announced that it is of"
  ["short_description"]=>
  string(150) "DENVER, March 11, 2020 /PRNewswire/ -- GroupSystems, the leading provider of digital engagement and workshop facilitation, has announced that it is of"
  [3]=>
  string(298) "
DENVER, March 11, 2020 /PRNewswire/ -- GroupSystems, the leading provider of digital engagement and workshop facilitation, has announced that it is offering new customers complimentary access to its platform for businesses with travel or budgetary restrictions driven by the recent spread...
"
  ["description"]=>
  string(298) "
DENVER, March 11, 2020 /PRNewswire/ -- GroupSystems, the leading provider of digital engagement and workshop facilitation, has announced that it is offering new customers complimentary access to its platform for businesses with travel or budgetary restrictions driven by the recent spread...
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "28"
  ["rss_id"]=>
  string(2) "28"
  [14]=>
  string(202) "https://www.prnewswire.com:443/news-releases/groupsystems-corp-offers-complimentary-access-to-its-thinktank-digital-engagement-platform-for-businesses-during-covid-19-coronavirus-outbreak-301021276.html"
  ["blog_url"]=>
  string(202) "https://www.prnewswire.com:443/news-releases/groupsystems-corp-offers-complimentary-access-to-its-thinktank-digital-engagement-platform-for-businesses-during-covid-19-coronavirus-outbreak-301021276.html"
  [15]=>
  string(19) "2020-03-11 13:00:00"
  ["add_date"]=>
  string(19) "2020-03-11 13:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:51"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

GroupSystems Corp. offers complimentary access to its ThinkTank® digital engagement pla

DENVER, March 11, 2020 /PRNewswire/ -- GroupSystems, the leading provider of digital engagement and workshop facilita